126 related articles for article (PubMed ID: 26472512)
1. Over-expression 5-aminolevulinic acid synthase 2 in nonerythroid cell may causes protoporphyrin IX accumulation.
Huang H; Wang W; Zou J; Liu Z; Zhou Z; Nakajima O; Zhang L; Luo J; Li M; He Q; Diao Y; Liang H; Zhou L; Gao X
Photodiagnosis Photodyn Ther; 2015 Oct; ():. PubMed ID: 26472512
[TBL] [Abstract][Full Text] [Related]
2. Over expression of 5-aminolevulinic acid synthase 2 increased protoporphyrin IX in nonerythroid cells.
Huang H; Wang W; Zou J; Nakajima O; Zhang L; He Q; Diao Y; Liang H; Zhou L; Peng Y
Photodiagnosis Photodyn Ther; 2017 Mar; 17():22-28. PubMed ID: 27777144
[TBL] [Abstract][Full Text] [Related]
3. Expression of murine 5-aminolevulinate synthase variants causes protoporphyrin IX accumulation and light-induced mammalian cell death.
Fratz EJ; Hunter GA; Ferreira GC
PLoS One; 2014; 9(4):e93078. PubMed ID: 24718052
[TBL] [Abstract][Full Text] [Related]
4. In ferrochelatase-deficient protoporphyria patients, ALAS2 expression is enhanced and erythrocytic protoporphyrin concentration correlates with iron availability.
Barman-Aksözen J; Minder EI; Schubiger C; Biolcati G; Schneider-Yin X
Blood Cells Mol Dis; 2015 Jan; 54(1):71-7. PubMed ID: 25179834
[TBL] [Abstract][Full Text] [Related]
5. Effect of delta-aminolevulinic acid on protoporphyrin IX accumulation in tumor cells transfected with plasmids containing porphobilinogen deaminase DNA.
Hilf R; Havens JJ; Gibson SL
Photochem Photobiol; 1999 Sep; 70(3):334-40. PubMed ID: 10483361
[TBL] [Abstract][Full Text] [Related]
6. Preclinical characterization of 5-amino-4-oxo-[6-11C]hexanoic acid as an imaging probe to estimate protoporphyrin IX accumulation induced by exogenous aminolevulinic acid.
Suzuki C; Tsuji AB; Kato K; Kikuchi T; Sudo H; Okada M; Sugyo A; Zhang MR; Arano Y; Saga T
J Nucl Med; 2014 Oct; 55(10):1671-7. PubMed ID: 25125482
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of Cancer-Specific Protoporphyrin IX Fluorescence by Targeting Oncogenic Ras/MEK Pathway.
Yoshioka E; Chelakkot VS; Licursi M; Rutihinda SG; Som J; Derwish L; King JJ; Pongnopparat T; Mearow K; Larijani M; Dorward AM; Hirasawa K
Theranostics; 2018; 8(8):2134-2146. PubMed ID: 29721068
[TBL] [Abstract][Full Text] [Related]
8. Identification and pharmacological modification of resistance mechanisms to protoporphyrin-mediated photodynamic therapy in human cutaneous squamous cell carcinoma cell lines.
Schary N; Novak B; Kämper L; Yousf A; Lübbert H
Photodiagnosis Photodyn Ther; 2022 Sep; 39():103004. PubMed ID: 35811052
[TBL] [Abstract][Full Text] [Related]
9. Delta-aminolevulinic acid synthase 2 expression in combination with iron as modifiers of disease severity in erythropoietic protoporphyria.
Barman-Aksözen J; Halloy F; Iyer PS; Schümperli D; Minder AE; Hall J; Minder EI; Schneider-Yin X
Mol Genet Metab; 2019 Nov; 128(3):304-308. PubMed ID: 31076252
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of delta aminolevulinic acid-photodynamic therapy in vivo by decreasing tumor pH with glucose and amiloride.
Piot B; Rousset N; Lenz P; Eléouet S; Carré J; Vonarx V; Bourré L; Patrice T
Laryngoscope; 2001 Dec; 111(12):2205-13. PubMed ID: 11802027
[TBL] [Abstract][Full Text] [Related]
11. Kinetic Evaluation of Determinant Factors for Cellular Accumulation of Protoporphyrin IX Induced by External 5-Aminolevulinic Acid for Photodynamic Cancer Therapy.
Nakanishi T; Ogawa T; Yanagihara C; Tamai I
J Pharm Sci; 2015 Sep; 104(9):3092-100. PubMed ID: 25959076
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of ABCG2 transporter by lapatinib enhances 5-aminolevulinic acid-mediated protoporphyrin IX fluorescence and photodynamic therapy response in human glioma cell lines.
Mansi M; Howley R; Chandratre S; Chen B
Biochem Pharmacol; 2022 Jun; 200():115031. PubMed ID: 35390338
[TBL] [Abstract][Full Text] [Related]
13. Effects of Silencing Heme Biosynthesis Enzymes on 5-Aminolevulinic Acid-mediated Protoporphyrin IX Fluorescence and Photodynamic Therapy.
Yang X; Li W; Palasuberniam P; Myers KA; Wang C; Chen B
Photochem Photobiol; 2015; 91(4):923-30. PubMed ID: 25809721
[TBL] [Abstract][Full Text] [Related]
14. Accumulation of protoporphyrin-IX (PpIX) in leukemic cell lines following induction by 5-aminolevulinic acid (ALA).
Bartosová J; Hrkal Z
Comp Biochem Physiol C Toxicol Pharmacol; 2000 Jul; 126(3):245-52. PubMed ID: 11048674
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of aminolevulinic acid-mediated protoporphyrin IX fluorescence and enhancement by ABCG2 inhibitors in renal cell carcinoma cells.
Howley R; Mansi M; Shinde J; Restrepo J; Chen B
J Photochem Photobiol B; 2020 Oct; 211():112017. PubMed ID: 32919173
[TBL] [Abstract][Full Text] [Related]
16. Regulation of 5-aminolevulinic acid-mediated protoporphyrin IX accumulation in human urothelial carcinomas.
Inoue K; Karashima T; Kamada M; Shuin T; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J
Pathobiology; 2009; 76(6):303-14. PubMed ID: 19955842
[TBL] [Abstract][Full Text] [Related]
17. In vitro study of biosynthesis of protoporphyrin IX induced by delta-aminolevulinic acid in normal and cancerous cells of the human cervix.
Gallegos ER; DeLeón Rodríguez I; Martínez Guzmán LA; Pérez Zapata AJ
Arch Med Res; 1999; 30(3):163-70. PubMed ID: 10427865
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic and Sonodynamic Therapy with Protoporphyrin IX: In Vitro and In Vivo Studies.
Ponce Ayala ET; Alves Dias de Sousa F; Vollet-Filho JD; Rodrigues Garcia M; de Boni L; Salvador Bagnato V; Pratavieira S
Ultrasound Med Biol; 2021 Apr; 47(4):1032-1044. PubMed ID: 33446374
[TBL] [Abstract][Full Text] [Related]
19. Experimental investigation of a combinational iron chelating protoporphyrin IX prodrug for fluorescence detection and photodynamic therapy.
Magnussen A; Reburn C; Perry A; Wood M; Curnow A
Lasers Med Sci; 2022 Mar; 37(2):1155-1166. PubMed ID: 34218351
[TBL] [Abstract][Full Text] [Related]
20. Silencing of human ferrochelatase causes abundant protoporphyrin-IX accumulation in colon cancer.
Kemmner W; Wan K; Rüttinger S; Ebert B; Macdonald R; Klamm U; Moesta KT
FASEB J; 2008 Feb; 22(2):500-9. PubMed ID: 17875605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
